Source: PubMed. Author: Jean-Michel Scherrmann

Scherrmann JM. Possible role of ABCB1 in lysosomal accumulation of azithromycin in COVID-19 therapy [published online ahead of print, 2020 Aug 17]. Clin Pharmacol Ther. 2020;10.1002/cpt.2020. doi:10.1002/cpt.2020

Abstract

The antiviral use of azithromycin in COVID-19 was recently reported by Damle et al. Its combination with hydroxychloroquine did not aim at preventing bacterial super-infection as often believed, but at benefiting from their common lysosomotropic properties which buffer the acidic conditions (pH 4-5) of the endolysosomal lumen where SARS-CoV-2 transits following its ACE-2 receptor-mediated endocytosis. These two powerful cationic and amphiphilic drugs increase up to neutrality the intravesicular pH causing disorders in lysosomal functions such as enzyme inhibitions involved in the virus replication cycle. We recently hypothesized that the ATP-binding cassette ABCB1 (P-glycoprotein) could be involved in this reported synergistic effect.



Related: The effect of 5-day course of hydroxychloroquine and azithromycin combination on QT interval in non-ICU COVID19(+) patients

Harvey Risch, Yale School of Medicine “The Key to Defeating COVID-19 Already Exists. We Need to Start Using It

The Epoch Times – Adam Carolla: Why Does the Media Shun Hydroxychloroquine?

Algeria: 90% of cases have responded very well to this treatment protocol – HCQ proves effective

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

Trouble in Paradise Surrounding the use of Ivermectin

In nations around the world tension mounts between physicians and caregivers seeking to prescribe what they professionally deem as safe doses of ivermectin, as an off-label treatment for COVID-19 and national health authorities, which for the most part have all taken a hostile and oppositional position against the use of the drug.

Read More »

How Ivermectin became a Target for the ‘Fraud Detectives.’

And why is ivermectin being so negatively targeted by Big Tech and Big Media? One could argue conflict of interest plays a major role, given how intertwined they are with Big Pharma and the far-reaching grasp of the BMGF. A cheap and effective early treatment for Covid-19, like ivermectin, can be seen as a significant threat to the financial interests of those involved with Covid vaccines and expensive anti-viral drugs.

Read More »

Canada: Alberta Failing on COVID-19 Vaccines and Treatment

Numerous studies and clinical observation of thousands of patients has indicated that Ivermectin is highly effective in this regard. Even low dose studies that were designed to reach the conclusion that ivermectin was not effective found a signal that indicated that Ivermectin effectively interacted with the COVID virus molecule to prevent or lessen replication of the virus.”

Read More »